Immediate Impact
1 from Science/Nature 55 standout
Citing Papers
Therapeutic resistance to anti-oestrogen therapy in breast cancer
2023 Standout
Estrogen Receptor Signaling in the Immune System
2022 Standout
Works of B. Thürlimann being referenced
Abstract PD1-03: Cholesterol, cholesterol lowering medication use, and breast cancer outcomes in the BIG 1-98 study
2016
Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90)
1997
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| B. Thürlimann | 108 | 42 | 55 | 15 | 143 | |
| Catherine Elliott | 79 | 44 | 47 | 10 | 128 | |
| Irene E.G. van Hellemond | 92 | 32 | 33 | 27 | 182 | |
| Kathi Malone | 116 | 38 | 51 | 10 | 221 | |
| Krystyna Reczko | 75 | 55 | 56 | 10 | 187 | |
| Lonneke W. Kessels | 120 | 66 | 16 | 12 | 178 | |
| L. Morales | 119 | 45 | 75 | 10 | 177 | |
| V. Labonia | 169 | 124 | 78 | 16 | 241 | |
| Pedro Emanuel Rubini Liedke | 130 | 66 | 62 | 20 | 233 | |
| Maria Grazia Razeti | 113 | 27 | 46 | 16 | 216 | |
| László Landherr | 120 | 59 | 34 | 20 | 188 |
All Works
Loading papers...